Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance
By L. Seguin, J. Desgrosellier, Sara M Weis, D. Cheresh. Trends in Cell Biology, 2015
651 citations recorded by the source corpus.
Summary Interactions between cancer cells and their surroundings can trigger essential signaling cues that determine cell fate and influence the evolution of the malignant phenotype. As the primary receptors involved in cell-matrix adhesion, integrins present on the surface of tumor and stromal cells have a profound impact on the ability to survive in specific locations, but in some cases these receptors can also function in the absence of ligand binding to promote stemness and survival in the presence of environmental and therapeutic stresses. Understanding how integrin expression and function is regulated in this context will enable the development of new therapeutic approaches to sensitize tumors to therapy and suppress their metastatic phenotype.
Subfields: Immunology and Allergy, Molecular Biology, Oncology
View Paper: https://www.semanticscholar.org/paper/4fe61173947bb2aa17e0bab80b98a61f9ff6362d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Immunology and Allergy
In Molecular Biology
In Oncology
Citations in the corpus
- The delivery of therapeutic oligonucleotides (2016, background): “While many integrins are rather ubiquitously expressed, there are several examples of tissue or disease state selective expression including alphaIIbbeta3 on platelets, beta2 integrins in leukocytes and alphavbeta3 expression in angiogenic endothelia and in certain tumors (92,93).”